While the Trump administration has in the past proposed international reference pricing for drug pricing in the U.S., a Health Affairs blog post suggests domestic reference pricing for COVID-19 therapies. Domestic reference pricing, Sean Dickson and Timothy Lash write, could help drive pricing […]
NPC Plans Webinar in Prices for COVID-19 Drugs
An upcoming webinar hosted by the National Pharmaceutical Council (NPC) will discuss a range of pricing-related issues for COVID-19 drugs. The online event, set to begin 3:30 p.m. EST July 14, will offer key insights from a panel of industry experts. Panelists include: Peter Bach, MD, […]
Hahn: Some COVID-19 Changes to Remain
Food and Drug Administration (FDA) Chief Stephen Hahn recently said some changes made to address COVID-19 will remain in place, Medical Design & Outsourcing reports. Hahn made the comments June 19 during a meeting with members of the Medical Device Innovation Consortium, according to the […]
Informa Pharma Intelligence Plans 24-Hour Webinar Series
Informa Pharma Intelligence is set to host a free, 24-hour interactive webinar series on the latest insights into COVID-19. The event is set to begin 4 a.m. EST. "This webinar event is meant to act as a true resource in compiling top industry insights on not only what's happening today, but […]
Blog Post Explores Novel Value Elements for Assessment of COVID-19 Drugs
A recent Health Affairs blog post suggests the inclusion of more novel value elements in the assessment of COVID-19 drugs is necessary. The blog post by Sachin Kamal-Bahl et al. offers a look at a number of non-traditional value elements, including fear of contagion, insurance and uncertainty, as […]
Opinion: Move Forward with Evidence-based Care as Foundation
Evidence-based care should be the bedrock of health care moving forward, the authors of a recent opinion piece published on The Hill suggest. The authors, John Rother, president of the National Coalition on Health Care, Katy Spangler, Smarter Health Care Coalition co-director, and Mark Fendrick, […]
Cytel Paper Offers Insight into Trial Recruitment Targets
A new white paper from Cytel offers insight into how recruitment targets are "met with sound starting assumptions and key modeling techniques." "In order to maximize the potential to achieve recruitment milestones and to avoid misleading trial projections, planning must take careful precautions […]
How Can HEOR Boost Outcomes?
The health economics and outcomes research (HEOR) framework can help facilitate more robust decision-making using "powerful data and insights," ISPOR Associate CSO Lucinda Orsini writes in an article published on HIMSS. "While both health economics and outcomes research can be performed in […]
Blog Post Touts VA, ICER Partnership as ‘Highly Beneficial’
The partnership between the Department of Veterans Affairs (VA) and the Institute for Clinical and Economic Review (ICER) has provided benefits across a number of fronts, according to a Health Affairs blog post by representatives of the agency and drug pricing watchdog. Despite concerns that the […]
Study Suggests Pfizer’s Vyndaqel is Too Expensive
A recent study published in JAMA Cardiology suggests the price tag on Pfizer's Vyndaqel is too high. According to a FiercePharma article, the heart medication received FDA approval in 2019, and hit the market with a $225,000 per year price tag. "Unfortunately, the high copays required by the […]
Sarepta Therapeutics’ Berry Talks Access to Rare Disease Treatments
Sarepta Therapeutics' Diane Berry in a recent Patients Rising Podcast discussed access to treatments for rare diseases. Berry is Sarepta Therapeutics' senior vice president of global health policy. "Patients with rare diseases may soon have better access to treatments," a description of the […]
Study: Almost 9 in 10 Concerned about High Drug Prices Due to COVID-19
Almost nine in 10 adults in the U.S. are either "very" (55 percent) or "somewhat" (33 percent) concerned pharma will use the COVID-19 pandemic to hike drug prices, according to a new study by West Health and Gallup. "As Americans brace for a potential second wave of coronavirus infections later […]
Updated Guide to HEOR/Market Access Writing Release
The 2020 update to "Evidence generation and communication: a guide to getting started in HEOR/market access medical writing" has been released. The guide is free to read, and is available online in PDF format. "This guide focuses on medical writing roles in the HEOR/market access arenas, but […]
ISPOR Offering Short Courses on Value Assessment Frameworks, HTA
The International Society of Pharmacoeconomics and Outcomes Research (ISPOR) is offering two short, online courses. Below are the two courses: A Health Economics Approach to US Value Assessment Frameworks, 10 a.m. EST June 23 Introduction to Health Technology Assessment, 10 a.m. EST June […]
Study: ICER Reports Play Major Role in MCOs’ Decisions
Many managed care organizations say they use reports by the Institute for Clinical and Economic Review (ICER) in their decision-making, according to new research by Xcenda. The research was conducted using data from the FormularyDecisions platform, according to a Managed Healthcare Executive […]
Joint Project Establishes RWD Link
ONC reported that the Coordinated Registry Network for Women's Health Technologies, a joint project involving ONC, the FDA and NIH, successfully established a real-world data-sharing framework, HealthITAnalytics reports. The initiative was launched in 2017, according to the report, and looked to […]
Report Highlights Growing Role of AI in Healthcare
A recent report by Alteryx offers a deeper look into new research from HIMSS Media which reveals new insights into the role of artificial intelligence in health care. The research found that while 75 percent of industry leaders said there would be more focus on AI and machine learning in the […]
ICON’s Row, Capobianco and Adamski Talk Increasing Participation in Real-World Studies
In a recent interview with PMLiVE, ICON plc's Bill Row, Bruce Capobianco and Maggie Adamski discussed ways to increase patient participation in real-world studies. During the interview, they said it's important to incorporate patient feedback in the earliest stages of […]
NIH Expands Precision Medicine Program to Improve Understanding of COVID-19
The National Institute of Health's All of Us precision medicine program announced an expanded initiative aimed at generating insights into the spread and effects of COVID-19, according to a HealthITAnalytics report. According to the report, All of Us will test some 10,000 blood samples from March […]
Fauci, Smith to Deliver Keynote Addresses for Virtual GHC Summit
Anthony Fauci, National Institute of Allergy and Infectious Disease director, and Brad Smith, CMMI director, have been tapped to deliver keynote addresses during GHC's upcoming virtual summit set to kick off June 22. The Virtual Summit on Health System Recovery from the COVID-19 Pandemic will […]
Guidehouse’s Austin Talks Waste in Supply Chain
Guidehouse Health Systems Director Rob Austin in a new Relentless Health Value podcast discusses the financial waste produced by mismanaged supply chains. Navigant suggests hospitals could save an average of $12 million each year with better management of their supply chain, according to a […]
Blog Post Urges Greater Understanding of Patient Experience Regarding De-implementation
A recent blog post on AcademyHealth says it is imperative to further study how patients deal with de-implementation. The authors, UCLA's Erin Hahn and Washington University School of Medicine's Beth Prusaczyk, write that the "patient experience of de-implementation is critically […]
MAPS Offering Course on AI in Medical Affairs
The Medical Affairs Professional Society (MAPS) is offering a course on the foundations of artificial intelligence in medical affairs. Open to both members and non-members, the course will focus on AI, machine learning, deep learning and natural language technologies. "With our course, we […]
Giri, Patel: Tough Road Ahead for Payers in Post-COVID Landscape
A recent article published in Managed Healthcare Executive looks at several key challenges payers will have to face in the post-COVID landscape. CitiusTech's Suman Giri and Shitang Patel suggest skyrocketing unemployment rates will be a significant hurdle for payers, with some 50 million […]
eBook Looks at How Providers, Payers Drive Outcomes-Based Analytics
A new report from Snowflake looks at how its cloud data solution and Tableau help providers and payers manage large, complex datasets. "Healthcare data is growing at an astronomical rate, prompting a new era in healthcare organizations," a description of the eBook states. "However, this presents […]
AcademyHealth’s Virtual Annual Research Meeting Nears
AcademyHealth's Annual Research Meeting is still on track to deliver the much-anticipated suite of offerings in a virtual environment. Set to kick off July 28, the virtual event will offer attendees 70 hours of online content. To see the event agenda on AcademyHealth's website, click […]
Study: Zero Co-Pay Program Reduced Health Spending by 18%
Blue Cross Blue Shield of Louisiana's (BCBSLA) Zero Dollar Co-pay (ZDC) program cut total, per-month health care spending by 18 percent, a new study published in AJMC suggests. The study by Xiaojing Yuan et al. also found a decrease in medical spending through the program, which was launched in […]
New JCP Series Looks at Progress of Clinical Pathways
A new series by the Journal of Clinical Pathways offers insight from board members on the growth of clinical pathways. Following are comments by some of the board members as part of the Ask the Board series: "As the move from fee-for-service to value-based care continues to evolve, the role of […]
Jeff Anderson Joins OPEN Health as European Lead for OPEN VIE and Pharmerit
Via Pharmerit OPEN Health, the family of expert practices working in partnership to drive positive change in healthcare communications and market access, has appointed Jeff Anderson as European Lead for the combined business across OPEN VIE and Pharmerit Europe. Jeff will report to COO, Sandy […]
Xcenda Report Highlights Digital Health Tech, Gene Therapies for Hemophilia
Xcenda's latest HTA Quarterly report shifts the spotlight to digital health technology, gene therapies for hemophilia and the EU's new guidance on digital health tech. Below are several articles featured in the newsletter: The Era of mHealth: A Global Perspective Emerging Gene Therapies […]
